435 results on '"MIYAKE, HIDEAKI"'
Search Results
2. MP60-10 COMPARISON OF UPFRONT ARAT THERAPY AND CAB THERAPY FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER: A RETROSPECTIVE MULTICENTER STUDY
3. PD23-05 THERAPEUTIC EFFECTS OF KCC2 CHLORIDE ION TRANSPORTER ACTIVATION ON DETRUSOR OVERACTIVITY IN MICE WITH SPINAL CORD INJURY
4. MP27-07 COMPARISON OF CLINICAL OUTCOMES BETWEEN ANDROGEN DEPRIVATION THERAPY WITH UP-FRONT ABIRATERONE AND BICALUTAMIDE FOR JAPANESE PATIENTS WITH LATITUDE HIGH-RISK PROSTATE CANCER IN A REAL-WORLD MULTICENTER ANALYSIS
5. MP18-17 KNOCKDOWN OF PD-L1 IN MOUSE RENAL CELL CARCINOMA INHIBITS TUMOR GROWTH AND IMPROVE THE ANTI-TUMOR EFFECT OF SUNITINIB
6. MP52-12 COMPARISON OF ALTERNATIVE ANDROGEN RECEPTOR-AXIS-TARGETED AGENT (ARATA) VERSUS DOCETAXEL AS SECOND-LINE THERAPY FOR PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PROGRESSING AFTER INITIAL ARATA IN REAL-WORLD CLINICAL PRACTICE IN JAPAN
7. PD19-10 P38 MITOGEN-ACTIVATED PROTEIN KINASE INHIBITOR REDUCES HYPEREXCITABILITY OF CAPSAICIN SENSITIVE BLADDER AFFERENT NEURONS IN MICE WITH SPINAL CORD INJURY
8. PD10-12 NO SIGNIFICANT IMPACT OF RESPONSE TO PRIOR ANDROGEN RECEPTOR-AXIS-TARGETED AGENTS ON THE EFFICACY OF SUBSEQUENT DOCETAXEL IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
9. MP88-06 EXPLORATION OF BIOMARKERS ASSOCIATED WITH PROGNOSIS IN PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA UNDERGOING SURGICAL RESECTION BY DESORPTION ELECTROSPRAY IONIZATION IMAGING MASS SPECTROMETRY
10. MP16-05 EARLY TUMOR SHRINKAGE UNDER SECOND-LINE TARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA AS A PREDICTOR OF OVERALL SURVIVAL: A RETROSPECTIVE MULTIINSTITUTIONAL STUDY IN JAPAN
11. PD24-01 COMPARATIVE ASSESSMENT OF EFFICACIES BETWEEN TWO ALTERNATIVE THERAPEUTIC SEQUENCES WITH NOVEL ANDROGEN RECEPTOR-AXIS-TARGETED AGENTS IN PATIENTS WITH CHEMOTHERAPY-NAIVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
12. MP70-19 THE ROLE OF UROCORTIN IN THE APOPTOSIS OF GERM CELLS AFTER EXPERIMENTAL TESTICULAR ISCHEMIA-REPERFUSION IN THE RAT
13. MP92-08 CLUSTERIN INHIBITION USING OGX-011 SYNERGISTICALLY ENHANCES ANTITUMOUR ACTIVITY OF AXITINIB IN A HUMAN RENAL CELL CARCINOMA MODEL
14. MP81-20 IRINOTECAN AND NEDAPLATIN AS SALVAGE THERAPY FOR PATIENTS WITH ADVANCED GERM CELL TUMOR FOLLOWING INTENSIVE TREATMENT WITH CISPLATIN-BASED COMBINATION CHEMOTHERAPIES
15. PD07-01 ASSESSMENT OF TIME-DEPENDENT CHANGES IN SEMEN PARAMETERS IN INFERTILE MEN FOLLOWING MICROSURGICAL VARICOCELECTOMY
16. MP41-15 RENAL FUNCTION AND PERIOPERATIVE OUTCOMES OF SELECTIVE VERSUS COMPLETE RENAL ARTERIAL CLAMPING DURING ROBOT-ASSISTED PARTIAL NEPHRECTOMY USING CONSOLE-INTEGRATED REAL-TIME THREE-DIMENSIONAL IMAGE OVERLAY NAVIGATION
17. MP70-18 SEMINAL LEVEL OF CLUSTERIN IN INFERTILE MEN AS A SIGNIFICANT BIOMARKER REFLECTING SPERMATOGENESIS
18. MP62-04 MOLECULAR MECHANISM MEDIATING CYTOTOXIC ACTIVITY OF CABAZITAXEL IN DOCETAXEL-RESISTANT HUMAN PROSTATE CANCER CELLS
19. MP61-11 ENHANCED SENSITIVITY TO NVP-BEZ235 BY INHIBITION OF P62/SQSTM1 IN HUMAN BLADDER CANCER KOTCC-1 CELLS BOTH IN VITRO AND IN VIVO
20. PD04-11 EXPRESSION LEVELS OF PD-L1 AND PD-L2 EXPRESSION IN RADICAL NEPHRECTOMY SPECIMENS AS PROGNOSTIC PREDICTORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH TYROSINE KINASE INHIBITORS
21. MP56-18 HEALTH-RELATED QUALITY OF LIFE AFTER RADICAL CYSTECTOMY: COMPARATIVE STUDY BETWEEN ORTHOTOPIC SIGMOID VERSUS ILEAL NEOBLADDERS
22. MP47-10 THE COMPARISON OF ERECTILE FUNCTION BETWEEN RADICAL NEPHRECTOMY GROUP AND PARTIAL NEPHRECTOMY GROUP.
23. PD04-08 PROGNOSTIC SIGNIFICANCE OF TUMOR EXTENT INTO THE VENOUS SYSTEM IN PATIENTS UNDERGOING SURGICAL TREATMENT FOR RENAL CELL CARCINOMA WITH VENOUS TUMOR THROMBUS
24. Bladder Neck Muscle Degeneration in Patients with Prostatic Hyperplasia
25. MP37-13 ACCELERATED CELL PROLIFERATION AND ENHANCED RESISTANCE TO DOCETAXEL BY INHIBITION OF 4E-BINDING PROTEIN 1 EXPRESSION IN HUMAN CASTRATION-RESISTANT PROSTATE CANCER PC3 CELLS
26. MP39-07 ACCELERATION OF PROTEINURIA WITHOUT SIGNIFICANT IMPACT ON RENAL FUNCTION AND ITS PROTECTION BY ANGIOTENSIN II RECEPTOR BLOCKER IN RATS TREATED WITH AXITINIB
27. MP39-06 ENHANCED CELL PROLIFERATION AND INCREASED RESISTANCE TO MAMMALIAN TARGET OF RAPAMYCIN INHIBITORS BY INHIBITION OF 4E-BINDING PROTEIN 1 EXPRESSION IN HUMAN RENAL CELL CARCINOMA ACHN CELLS
28. PD35-02 EARLY TUMOR SHRINKAGE UNDER FIRST-LINE TYROSINE KINASE INHIBITOR AS A SURROGATE ENDPOINT OF OVERALL SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
29. MP64-01 EXPRESSION PROFILE OF EPITHELIAL-MESENCHYMAL TRANSITION MARKERS IN RADICAL CYSTECTOMY SPECIMENS: COMPARATIVE STUDY BETWEEN UROTHELIAL AND BILHARZIAL SQUAMOUS CELL CARCINOMAS OF THE BLADDER
30. MP39-08 CLUSTERIN INHIBITION USING OGX-011 SYNERGISTICALLY ENHANCES ANTITUMOR ACTIVITY OF TEMSIROLIMUS IN A HUMAN RENAL CELL CARCINOMA MODEL
31. MP10-14 EFFICACY AND TOLERABILITY OF TIP (PACLITAXEL, IFOSFAMIDE AND CISPLATIN) INCORPORATED INTO INDUCTION CHEMOTHERAPY FOR PATIENTS WITH INTERMEDIATE- OR POOR-RISK METASTATIC GERM CELL TUMORS
32. MP69-10 ASSESSMENT OF EFFICACY, SAFETY AND QUALITY OF LIFE OF 110 PATIENTS TREATED WITH SUNITINIB AS FIRST-LINE THERAPY FOR METASTATIC RENAL CELL CARCINOMA: EXPERIENCE IN REAL WORLD CLINICAL PRACTICE IN JAPAN
33. MP17-17 SIGNIFICANCE OF URETHRAL FIBROSIS EVALUATED BY PREOPERATIVE MAGNETIC RESONANCE IMAGING AS A PREDICTOR OF CONTINENCE STATUS AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY
34. PD18-03 CONSOLE-INTEGRATED REAL-TIME THREE-DIMENSIONAL IMAGE OVERLAY NAVIGATION FOR ROBOT-ASSISTED PARTIAL NEPHRECTOMY WITH SELECTIVE ARTERIAL CLAMPING: EARLY SINGLE-CENTER EXPERIENCE WITH 25 CASES
35. MP56-09 EXPRESSION PROFILE OF CD44S, CD44V6, AND CD44V10 IN LOCALIZED PROSTATE CANCER: IMPACT ON PROGNOSTIC OUTCOMES FOLLOWING RADICAL PROSTATECTOMY
36. MP76-11 IDENTIFICATION OF SPERMATOGENICALLY ACTIVE REGIONS IN RAT TESTIS BY USING NARROW BAND IMAGING SYSTEM.
37. MP39-20 MOLECULAR MECHANISM UNDERLYING CYTOTOXIC ACTIVITY OF AXITINIB IN SUNITINIB-RESISTANT HUMAN RENAL CELL CARCINOMA ACHN CELLS
38. PD31-02 PERFORMANCE STATUS AS A SIGNIFICANT PREDICTOR FOR BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY
39. MP57-08 SIGNIFICANCE OF GERIATRIC NUTRITIONAL RISK INDEX AS A PROGNOSTIC PREDICTOR IN PATIENTS WITH NON-METASTATIC RENAL CELL CARCINOMA UNDERGOING SURGICAL RESECTION
40. PD8-10 ARE OUR DAILY CLINICS FOLLOWING GUIDELINES FOR PREVENTION OF SURGICAL SITE INFECTION?
41. Histological Study of the Cavernous Nerve Mesh Outside the Periprostatic Region: Anatomical Basis for Erectile Function after Nonnerve Sparing Radical Prostatectomy
42. OP2-07 LONG-TERM OBSERVATION OF CHANGES IN RENAL FUNCTION FOLLOWING RADICAL CYSTECTOMY AND URINARY DIVERSION
43. MP35-04 ENHANCED SENSITIVITY TO SORAFENIB BY INHIBITION OF AKT1 EXPRESSION IN HUMAN RENAL CELL CARCINOMA ACHN CELLS BOTH IN VITRO AND IN VIVO
44. MP8-07 EMERGENCE OF EXTENDED SPECTRUM BETA-LACTAMASE PRODUCING ESCHERICHIA COLI IN CATHETER ASSOCIATED URINARY TRACT INFECTION (CAUTI) IN NEUROGENIC BLADDER PATIENTS
45. MP56-03 EXPRESSION PROFILE OF EPITHELIAL-MESENCHYMAL TRANSITION MARKERS IN NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER: CORRELATION WITH INTRAVESICAL RECURRENCE FOLLOWING TRANSURETHRAL RESECTION
46. MP52-08 TARGETING IGFBP-2 AND IGFBP-5 IN CASTRATION AND ENZALUTAMIDE RESISTANT PROSTATE CANCER
47. MP66-08 CLUSTERIN PRODUCED BY SERTOLI CELLS INHIBITS HEAT STRESS-INDUCED APOPTOSIS IN RAT TESTIS
48. MP24-16 ENHANCED SENSITIVITY TO SUNITINIB BY INHIBITION OF AKT1 EXPRESSION IN HUMAN CASTRATION-RESISTANT PROSTATE CANCER PC3 CELLS BOTH IN VITRO AND IN VIVO
49. MP66-01 LOSS OF RA-GEF-2 (RAPGEF6) IN MOUSE CAUSES ALTERED LOCALIZATION OF N-CADHERIN AND CAN CAUSE MALE INFERTILITY
50. MP4-18 SIGNIFICANT RECEPTORS OR BIOMARKERS FOR THE SYMPTOMS OF OVERACTIVE BLADDER
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.